title: CHLVPP therapy for Hodgkin's disease identification of prognostic factors.
authors.affiliation: Department of Internal Medicine, University of Nebraska, Medical Center, Omaha, USA.
authors.forename: J M
authors.initials: JM
authors.lastname: Vose
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002699:Chlorambucil / Q000008:administration & dosage; D018572:Disease-Free Survival; D006689:Hodgkin Disease / Q000188:drug therapy* / Q000401:mortality; D006801:Humans; D011239:Prednisolone / Q000008:administration & dosage; D011344:Procarbazine / Q000008:administration & dosage; D014747:Vinblastine / Q000008:administration & dosage
chemical_list: D002699:Chlorambucil; D011344:Procarbazine; D014747:Vinblastine; D011239:Prednisolone